A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
Insulin signaling regulates blood glucose by stimulating glucose uptake, glycogen synthesis, and lipogenesis while inhibiting gluconeogenesis and fatty acid oxidation. Binding of insulin to insulin receptor tyrosine kinase initiates GLUT4 translocation to cell membranes, enabling glucose uptake in muscle and adipose tissue. Chronic hyperinsulinemia can lead to desensitization of insulin signaling pathways (insulin resistance), impairing glucose disposal despite elevated insulin levels.
Trace the insulin receptor signaling cascade from ligand binding through GLUT4 translocation. Compare postprandial glucose and insulin responses to different macronutrient compositions to understand how nutrient timing and type affect insulin secretion.
You already know from your prerequisites that after a meal, glucose enters the bloodstream and rises, triggering insulin secretion from pancreatic beta cells; that glucagon does the opposite — rising when glucose falls, stimulating hepatic glucose output; and that hormone receptors transduce extracellular signals into intracellular responses through cascades of protein modifications. Insulin signaling is the specific molecular story of how the insulin signal travels from the receptor on the cell surface to the metabolic machinery inside the cell, and understanding this pathway is what makes insulin resistance comprehensible rather than mysterious.
The insulin receptor is a receptor tyrosine kinase (RTK) — a type you may recognize from your hormone receptor signaling prerequisite. When insulin binds to the extracellular alpha subunits, it induces a conformational change that activates the intracellular beta subunits' kinase activity. The receptor then autophosphorylates (phosphorylates itself on tyrosine residues), creating docking sites for downstream signaling proteins. The primary docking protein is IRS-1 (insulin receptor substrate-1). Phosphorylated IRS-1 recruits and activates PI3K (phosphoinositide 3-kinase), which converts membrane lipid PIP₂ to PIP₃. PIP₃ is a second messenger that recruits PDK1, which in turn activates Akt (also called protein kinase B). This IRS-1 → PI3K → PIP₃ → PDK1 → Akt cascade is the central signal relay. Each step amplifies the signal, which is why a small change in circulating insulin can produce large downstream metabolic effects.
Akt is the key effector. It phosphorylates multiple target proteins simultaneously, coordinating the metabolic response. In muscle and adipose tissue, Akt stimulates translocation of GLUT4 glucose transporters from intracellular vesicles to the plasma membrane — the primary mechanism of insulin-stimulated glucose uptake. At rest, GLUT4 is sequestered inside the cell; insulin signaling tells the vesicles to fuse with the membrane, increasing surface GLUT4 density roughly 10-fold. In the liver, Akt activates glycogen synthase (via phosphorylation of GSK-3, which normally inhibits it) and suppresses gluconeogenesis by phosphorylating and inactivating FOXO transcription factors, which drive gluconeogenic gene expression. The net result of Akt activation is simultaneous glucose uptake in peripheral tissues and suppression of hepatic glucose production — a coordinated clamp on blood glucose from both the demand and supply sides.
Insulin resistance occurs when this signaling cascade is blunted at one or more steps. The most common mechanism in obesity is serine phosphorylation of IRS-1 — inflammatory cytokines and fatty acid metabolites activate kinases (JNK, IKK) that phosphorylate IRS-1 at serine residues rather than tyrosine residues. This inhibitory phosphorylation prevents IRS-1 from docking correctly with PI3K, breaking the cascade early. The pancreas compensates by secreting more insulin (hyperinsulinemia), which maintains glucose levels initially but accelerates beta-cell burnout over time. Exercise improves insulin sensitivity partly by increasing GLUT4 expression and partly by activating an insulin-independent pathway (AMPK → GLUT4 translocation), explaining why exercise is therapeutic for insulin-resistant individuals even when their insulin signaling is impaired.